Dunn Gordon
SEC CIK 1958139 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| QNRX | Quoin Pharmaceuticals Ltd. | CFO | 151.1K | $78.2K | — | 2 | 2024-09-09 | 2024-12-23 |
Most active insiders at QNRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LANGER DENNIS | Dir | $128.6K | — |
| 2 | Myers Michael | CEO, Dir | $100.0K | — |
| 3 | Carter Denise P. | COO, Dir | $100.0K | — |
| 4 | Lawlor Sally Bridget | CFO | $50.0K | — |
| 5 | Culverwell Anthony James | Dir | $30.0K | — |
Dunn Gordon made no open-market trades at QNRX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-27 | 2024-12-23 | QNRX | Quoin Pharmaceuticals Ltd. | Dunn Gordon | CFO | P - Purchase | $0.45 | +122.2K | 151.1K | +424% | +$55.0K |
| M | 2024-09-11 | 2024-09-09+ | QNRX | Quoin Pharmaceuticals Ltd. | Dunn Gordon | CFO | P - Purchase | $0.8042 | +28.9K | 28.9K | New | +$23.2K |
Purchase Sale Sale after option exercise All abbreviations